Symbiotec Pharmalab Ltd. IPO

Min Investment

₹ 14,820 / 15 shares

Price Range

₹938 - ₹ 988

Bidding Dates

24 Aug '26 - 27 Aug '26

Total Issue Value

1,757.00 Cr

Lot Size

15

Total Issue Size

1,757.00 Cr

Listing At

IPO Timeline

• 24 Aug 2026

  Bidding Starts
• 27 Aug 2026

  Bidding Ends
• 28 Aug 2026

  Allotment Finalization
• 1 Sep 2026

  Listing

About Symbiotec Pharmalab Ltd.

Parent organisation

Founded

Symbiotec Pharmalab Ltd.

2002

Symbiotec Pharmalab Ltd. IPO Reservation

Investors Category	Shares Offered
Anchor Investors	53,25,911 (29.95%)
Employee Reserved	30,364 (0.17%)
Non Institutional Investors	26,62,955 (14.97%)
Qualified Institutional Buyers (QIBs)	35,50,607 (19.97%)
Retail Individual Investors (RIIs)	62,13,563 (34.94%)

Symbiotec Pharmalab Ltd. IPO Listing Details

Listing Date

1 Sep 2026

ISIN

INE899I01010

Final Issue Price

₹ 988

Symbiotec Pharmalab Ltd. IPO Registrar

MUFG Intime India Pvt. Ltd.

C-101, 1st Floor, 247 Park, Lal Bahadur Shastri Marg, Vikhroli (West), Mumbai Maharashtra - 400083

8108114949

Symbiotec Pharmalab Ltd. IPO Lead Manager(s)

Avendus Capital Pvt. Ltd.

Platina Building, 9th Floor 901, Plot No C-59 Bandra-Kurla Complex, Bandra (East), Mumbai Maharashtra - 400051

66480050

FAQs

When does Symbiotec Pharmalab Ltd. IPO opens and closes?

Symbiotec Pharmalab Ltd. IPO opens from 24th August to 27th August 2026.

What is the size of Symbiotec Pharmalab Ltd. IPO?

The size of the Symbiotec Pharmalab Ltd. IPO is ₹1,757.00 Cr.

What is the price range of Symbiotec Pharmalab Ltd. IPO?

The price range of Symbiotec Pharmalab Ltd. IPO is at ₹938 to ₹988 per share.

What is the minimum investment and lot size required for the Symbiotec Pharmalab Ltd. IPO?

The minimum investment required is ₹14,820 and minimum lot size is 15 shares.

When is Symbiotec Pharmalab Ltd. IPO listing date?

The Symbiotec Pharmalab Ltd. IPO will be listed on 1st September 2026.

Who are the book runners for Symbiotec Pharmalab Ltd. IPO?

Avendus Capital Pvt. Ltd. is the book-running lead manager for Symbiotec Pharmalab Ltd. IPO.